Document Detail

Expression of osteoprotegerin and RANK ligand in breast cancer bone metastasis.
Jump to Full Text
MedLine Citation:
PMID:  12923331     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Bone destruction is primarily mediated by osteoclastic bone resorption, and cancer cells stimulate the formation and activation of osteoclasts next to metastatic foci. Accumulating evidences indicate that receptor activator of NF-kB ligand (RANKL) is the ultimate extracellular mediator that stimulates osteoclast differentiation into mature osteoclasts. In contrast, osteoprotegerin (OPG) inhibits osteoclast development. In order to elucidate a mechanism for cancer-induced osteoclastogenesis, cells from a human breast cancer line, MDA-MB-231, were directly co-cultured with ST2, MC3T3-E1, or with primary mouse calvarial cells. Osteoclast-like cells and tartarate resistant acid phosphatase (TRAP) activities were then quantitated. We examined these cell lines and samples from breast cancer by RT-PCR for the expressions of OPG and RANKL mRNA. Compared to controls, co-culture of MDA-MB-231 cells with stromal or osteoblastic cells induced an increase in number of osteoclasts and TRAP activities. MDA-MB-231 cells alone or breast cancer samples did not express RANKL mRNA. However, co-culture of these cancer cells with stromal or osteoblastic cells induced RANKL mRNA expression and decreased OPG mRNA expression. These experiments demonstrate that direct interactions between breast cancer and stromal or osteoblastic cells induce osteoclastogenesis in vitro through modulating RANKL expression.
Authors:
Hye-Rim Park; Soo-Kee Min; Hyun-Deuk Cho; Duck-Hwan Kim; Hyung Sik Shin; Young Euy Park
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of Korean medical science     Volume:  18     ISSN:  1011-8934     ISO Abbreviation:  J. Korean Med. Sci.     Publication Date:  2003 Aug 
Date Detail:
Created Date:  2003-08-18     Completed Date:  2004-04-30     Revised Date:  2011-03-16    
Medline Journal Info:
Nlm Unique ID:  8703518     Medline TA:  J Korean Med Sci     Country:  Korea (South)    
Other Details:
Languages:  eng     Pagination:  541-6     Citation Subset:  IM    
Affiliation:
Department of Pathology, College of Medicine, Hallym University, Chuncheon, Korea. hyerim@chol.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
3T3 Cells
Acid Phosphatase / metabolism
Animals
Bone Neoplasms / metabolism*,  secondary*
Breast Neoplasms / pathology*
Carrier Proteins / biosynthesis*
Cell Differentiation
Cell Line, Tumor
Cells, Cultured
Coculture Techniques
Culture Media, Conditioned / pharmacology
Glycoproteins / biosynthesis*
Humans
Isoenzymes / metabolism
Male
Membrane Glycoproteins / biosynthesis*
Mice
Mice, Inbred C57BL
Neoplasm Metastasis
Osteoblasts / metabolism
Osteoclasts / metabolism
Osteoprotegerin
Protein Binding
RANK Ligand
RNA, Messenger / metabolism
Receptor Activator of Nuclear Factor-kappa B
Receptors, Cytoplasmic and Nuclear / biosynthesis*
Receptors, Tumor Necrosis Factor
Reverse Transcriptase Polymerase Chain Reaction
Time Factors
Chemical
Reg. No./Substance:
0/Carrier Proteins; 0/Culture Media, Conditioned; 0/Glycoproteins; 0/Isoenzymes; 0/Membrane Glycoproteins; 0/Osteoprotegerin; 0/RANK Ligand; 0/RNA, Messenger; 0/Receptor Activator of Nuclear Factor-kappa B; 0/Receptors, Cytoplasmic and Nuclear; 0/Receptors, Tumor Necrosis Factor; 0/TNFRSF11A protein, human; 0/TNFRSF11B protein, human; 0/TNFSF11 protein, human; 0/Tnfrsf11a protein, mouse; 0/Tnfrsf11b protein, mouse; 0/Tnfsf11 protein, mouse; EC 3.1.3.-/tartrate-resistant acid phosphatase; EC 3.1.3.2/Acid Phosphatase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): J Korean Med Sci
Journal ID (pmc): jkms
ISSN: 1011-8934
ISSN: 1598-6357
Publisher: Korean Academy of Medical Sciences
Article Information
Download PDF

Print publication date: Month: 8 Year: 2003
Volume: 18 Issue: 4
First Page: 541 Last Page: 546
ID: 3055084
PubMed Id: 12923331
Publisher Item Identifier: 200308541

Expression of osteoprotegerin and RANK ligand in breast cancer bone metastasis.
Hye-Rim Park Email: hyerim@chol.com
Soo-Kee Min
Hyun-Deuk Cho
Duck-Hwan Kim
Hyung Sik Shin
Young Euy Park
Department of Pathology, College of Medicine, Hallym University, Chuncheon, Korea.


Article Categories:
  • Research Article


Previous Document:  Intake of dietary fat and vitamin in relation to breast cancer risk in Korean women: a case-control ...
Next Document:  Short-term effect of partially hydrolyzed formula on the prevention of development of atopic dermati...